Timothy W. Trost
2021 - Werewolf Therapeutics
In 2021, Timothy W. Trost earned a total compensation of $2.1M as Chief Financial Officer at Werewolf Therapeutics.
Compensation breakdown
| Bonus | $142,000 |
|---|---|
| Option Awards | $1,608,910 |
| Salary | $337,793 |
| Other | $1,346 |
| Total | $2,090,049 |
Trost received $1.6M in option awards, accounting for 77% of the total pay in 2021.
Trost also received $142K in bonus, $337.8K in salary and $1.3K in other compensation.
Rankings
In 2021, Timothy W. Trost's compensation ranked 5,884th out of 12,415 executives tracked by ExecPay. In other words, Trost earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,884 out of 12,415 | 53rd |
Division Manufacturing | 2,488 out of 5,508 | 55th |
Major group Chemicals And Allied Products | 1,080 out of 2,378 | 55th |
Industry group Drugs | 961 out of 2,099 | 54th |
Industry Pharmaceutical Preparations | 691 out of 1,549 | 55th |
Source: SEC filing on April 22, 2022.
Trost's colleagues
We found four more compensation records of executives who worked with Timothy W. Trost at Werewolf Therapeutics in 2021.